News

what is the rosa 26 knock-in
The Utility of the Rosa26 Knock-in Mouse

The Rosa26 locus in the mouse genome is a “safe harbor” which allows researchers to express genes of interest. Different gene targeting technologies (embryonic stem…

Read more
RenMab™ Mouse Featured in GEN Magazine

Biocytogen's RenMab™ Mouse is featured in the Nov. Issue of Genetic Engineering & Biotechnology News (GEN). Read the full article here.  RenMab™ Mouse highlights: Developed…

Read more
Biocytogen’s RenMab™ Mouse is Featured on Fiercebiotech

Biocytogen's RenMab™ Mouse is featured on Fiercebiotech.com today. Read the full article here.  RenMab™ Mouse highlights: Developed upon Biocytogen’s unique Mb-scale chromosome engineering technology Variable…

Read more
2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

Location: Hilton Garden Inn Philadelphia Center City Dates: Sept. 19-20, 2019 Booth: #Ex-7 Presentation Title: Accelerating Therapeutic Antibody Discovery and Development with Innovative Humanized Mouse…

Read more
mouse-on-top-of-medicine
Biocytogen Closes $79M Series D Funding

On August 2019, Beijing Biocytogen Co., Ltd. ("Biocytogen") announced the closing of its Series D funding of $79M (RMB 543M). This round of financing was…

Read more
Harvard-China-2
Biocytogen’s President & CEO, Dr. Yuelei Shen, Speaks at Harvard China Forum at Harvard University

Harvard College China Forum, an annual Harvard tradition for 22 years, welcomed and opened to 1,200 domestic and international participants and over 100 domestic and…

Read more
Biocytogen’s Integrated One-stop Preclinical Services and the RenMab Mouse Shine at AACR 2019

American Association for Cancer Research (AACR) Annual Meeting 2019 was held in Atlanta, Georgia from March 29 to April 3, 2019, with a theme of “Integrative…

Read more
Former Swedish Prime Minister Visits Biocytogen

Former Swedish Prime Minister, former president of the European Council Mr. Fredrik Reinfeldt and Executive Chairman of Nordic Growth Technology (NGT) Partners, professor Niclas Adler…

Read more
Immuno-Oncology (IO) Summit 2018

Biocytogen attended Immuno-Oncology (IO) Summit 2018 congress in Boston, MA, Aug 28 - Aug 31. IO Summit has become the leading annual meeting focusing on…

Read more
Biocytogen showcases innovative gene-editing strategies at Experimental Biolo

BiocytogenTM Gene Targeting Services participated at the Experimental Biology (EB) 2018 meeting in San Diego, CA, April 22-24. This conference was comprised of more than…

Read more
Back to top